Modulation of Immune Responses against HA1 Influenza Vaccine Candidate by B-lymphocyte Stimulator Cytokine in Mice

Seyedeh Mahsa  Bagheri Yazdi; Shahla Shahsavandi; Fatemeh Fotouhi; Majid Tebianian; Mohammad Majid  Ebrahimi

doi:10.18502/ijaai.v21i2.9228

Seyedeh Mahsa Bagheri Yazdi Razi Vaccine and Serum Research Institute, Agricultural Research Education and Extension Organization, Karaj, Iran
Shahla Shahsavandi Razi Vaccine and Serum Research Institute, Agricultural Research Education and Extension Organization, Karaj, Iran
Fatemeh Fotouhi Department of Influenza, Pasteur Institute of Iran, Tehran, Iran
Majid Tebianian Razi Vaccine and Serum Research Institute, Agricultural Research Education and Extension Organization, Karaj, Iran
Mohammad Majid Ebrahimi Razi Vaccine and Serum Research Institute, Agricultural Research Education and Extension Organization, Karaj, Iran

DOI: https://doi.org/10.18502/ijaai.v21i2.9228

Keywords: B cell-activating factor receptor; Hemagglutinins; Immunity; Influenza A virus H1N1 subtype

Abstract

Utilizing subunit vaccines is one of the strategies to address influenza infection. Recent innovations have focused on high doses of vaccine antigens and immune enhancers or adjuvants to induce more robust and long-lasting immune responses. Here, an effect of the B cell-activating factor receptor (BAFF-R) to increase the magnitude and durability of immune responses of the recombinant HA1 (rHA1) protein against the H1N1 influenza virus was studied.

The HA1 protein and the effector domain of BAFF-R were expressed in the pET-28a (+) vector. Eight-week-old BALB/c mice were equally grouped into five groups (n=20). The 15 and 25 μg/μL of rHA1 were mixed with 2 μg/μL of rBAFF-R and injected three times for vaccinated groups. Three control groups received normal saline and two concentrations of rHA1. The ability of rBAFF-R in eliciting HA-specific antibody response and stimulating T lymphocyte proliferation to induce the cell-mediated immunity was assayed. Induction of protection was evaluated following the challenge with PR8 strain.

Analysis of immune responses showed that the co-administration of rBAFF-R with rHA1 boosted HI responses to the antigen in mice, whilst it was not able to promote the T cell proliferation responses against influenza. Compared to rHA1alone, the rBAFF-R/rHA1 generated efficient protection for the animals. There were no significant differences in eliciting the immune responses in mice immunized with the lower dose of rHA1 than that with the higher dose.

The data indicate the rBAFF-R can enhance the primary and memory immune responses to protect against influenza infection.